October 24, 2016 11:57 AM ET


Company Overview of Aralez Pharmaceuticals Inc.

Executive Profile

Adrian Adams

Chief Executive Officer, Director and Member of Transaction Committee, Aralez Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 10 different industries.

See Board Relationships
As of Fiscal Year 2015


Mr. Adrian Adams has been the Chief Executive Officer of Aralez Pharmaceuticals Inc. (Pozen Inc.) since June 1, 2015. Mr. Adams served as the Chief Executive Officer and President at Auxilium Pharmaceuticals Inc. from December 8, 2011 to January 29, 2015. He served as the Chief Executive Officer of Neurologix Inc. from September 19, 2011 to November 30, 2011. He served as the Chief Executive Officer and President of Inspire Pharmaceuticals, Inc. since February 22, 2010. ...

Corporate Headquarters

151 Steeles Avenue East
Milton, Ontario L9T 1Y1


Phone: 905-876-1118
Fax: --

Board Members Memberships

Chief Executive Officer and Director
Director, Chairman of Compensation & Human Resources Committee and Member of Corporate Governance Committee
Chairman, Member of Compensation Committee, Member of Nominating & Corporate Governance Committee and Member of Audit Committee
Chief Executive Officer, Director and Member of Transaction Committee


University of Manchester
Unknown/Other Education
Salford University

Other Affiliations

Annual Compensation

Total Annual Compensation$410,217

Stocks Options

Restricted Stock Awards$14,858,944
All Other Compensation$197,882

Total Compensation

Total Annual Cash Compensation$1,016,432
Total Short Term Compensation$410,217
Other Long Term Compensation$15,056,826
Total Calculated Compensation$15,875,376

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Paul V. Campanelli Chief Executive Officer, President and Director
Endo International plc
Daniel N. Swisher Jr.Chief Executive Officer, President and Director
Sunesis Pharmaceuticals, Inc.
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co., Inc.
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Aralez Pharmaceuticals Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.